These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35743167)

  • 41. Architecture of a lymphomyeloid developmental switch controlled by PU.1, Notch and Gata3.
    Del Real MM; Rothenberg EV
    Development; 2013 Mar; 140(6):1207-19. PubMed ID: 23444353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MIR-23A microRNA cluster inhibits B-cell development.
    Kong KY; Owens KS; Rogers JH; Mullenix J; Velu CS; Grimes HL; Dahl R
    Exp Hematol; 2010 Aug; 38(8):629-640.e1. PubMed ID: 20399246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Macrophage development from HSCs requires PU.1-coordinated microRNA expression.
    Ghani S; Riemke P; Schönheit J; Lenze D; Stumm J; Hoogenkamp M; Lagendijk A; Heinz S; Bonifer C; Bakkers J; Abdelilah-Seyfried S; Hummel M; Rosenbauer F
    Blood; 2011 Aug; 118(8):2275-84. PubMed ID: 21730352
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia.
    Will B; Vogler TO; Narayanagari S; Bartholdy B; Todorova TI; da Silva Ferreira M; Chen J; Yu Y; Mayer J; Barreyro L; Carvajal L; Neriah DB; Roth M; van Oers J; Schaetzlein S; McMahon C; Edelmann W; Verma A; Steidl U
    Nat Med; 2015 Oct; 21(10):1172-81. PubMed ID: 26343801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The RUNX1-PU.1 axis in the control of hematopoiesis.
    Imperato MR; Cauchy P; Obier N; Bonifer C
    Int J Hematol; 2015 Apr; 101(4):319-29. PubMed ID: 25749719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia.
    Rimmelé P; Esposito M; Delestré L; Guervilly JH; Ridinger-Saison M; Despras E; Moreau-Gachelin F; Rosselli F; Guillouf C
    Oncotarget; 2017 Jun; 8(23):37104-37114. PubMed ID: 28415748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy.
    Gu X; Hu Z; Ebrahem Q; Crabb JS; Mahfouz RZ; Radivoyevitch T; Crabb JW; Saunthararajah Y
    J Biol Chem; 2014 May; 289(21):14881-95. PubMed ID: 24695740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Granulocytic differentiation of normal hematopoietic precursor cells induced by transcription factor PU.1 correlates with negative regulation of the c-myb promoter.
    Bellon T; Perrotti D; Calabretta B
    Blood; 1997 Sep; 90(5):1828-39. PubMed ID: 9292515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cells.
    De Marchis ML; Ballarino M; Salvatori B; Puzzolo MC; Bozzoni I; Fatica A
    Leukemia; 2009 May; 23(5):856-62. PubMed ID: 19151778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The importance of PU.1 concentration in hematopoietic lineage commitment and maturation.
    Dahl R; Simon MC
    Blood Cells Mol Dis; 2003; 31(2):229-33. PubMed ID: 12972030
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PU.1 silencing leads to terminal differentiation of erythroleukemia cells.
    Atar O; Levi BZ
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1288-92. PubMed ID: 15766566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of the autophagy-associated gene MAP1S via PU.1 supports APL differentiation.
    Haimovici A; Brigger D; Torbett BE; Fey MF; Tschan MP
    Leuk Res; 2014 Sep; 38(9):1041-7. PubMed ID: 25043887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sensitivity of MLL-rearranged AML cells to all-trans retinoic acid is associated with the level of H3K4me2 in the RARα promoter region.
    Sakamoto K; Imamura T; Yano M; Yoshida H; Fujiki A; Hirashima Y; Hosoi H
    Blood Cancer J; 2014 Apr; 4(4):e205. PubMed ID: 24769646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.
    Fu L; Shi J; Liu A; Zhou L; Jiang M; Fu H; Xu K; Li D; Deng A; Zhang Q; Pang Y; Guo Y; Hu K; Zhou J; Wang Y; Huang W; Jing Y; Dou L; Wang L; Xu K; Ke X; Nervi C; Li Y; Yu L
    Int J Cancer; 2017 Feb; 140(3):653-661. PubMed ID: 27770540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heterozygous deletion of the PU.1 locus in human AML.
    Bonadies N; Pabst T; Mueller BU
    Blood; 2010 Jan; 115(2):331-4. PubMed ID: 19890096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia.
    Khalife J; Radomska HS; Santhanam R; Huang X; Neviani P; Saultz J; Wang H; Wu YZ; Alachkar H; Anghelina M; Dorrance A; Curfman J; Bloomfield CD; Medeiros BC; Perrotti D; Lee LJ; Lee RJ; Caligiuri MA; Pichiorri F; Croce CM; Garzon R; Guzman ML; Mendler JH; Marcucci G
    Leukemia; 2015 Oct; 29(10):1981-92. PubMed ID: 25971362
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dual regulation of SPI1/PU.1 transcription factor by heat shock factor 1 (HSF1) during macrophage differentiation of monocytes.
    Jego G; Lanneau D; De Thonel A; Berthenet K; Hazoumé A; Droin N; Hamman A; Girodon F; Bellaye PS; Wettstein G; Jacquel A; Duplomb L; Le Mouël A; Papanayotou C; Christians E; Bonniaud P; Lallemand-Mezger V; Solary E; Garrido C
    Leukemia; 2014 Aug; 28(8):1676-86. PubMed ID: 24504023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia.
    De Luca L; Trino S; Laurenzana I; Tagliaferri D; Falco G; Grieco V; Bianchino G; Nozza F; Campia V; D'Alessio F; La Rocca F; Caivano A; Villani O; Cilloni D; Musto P; Del Vecchio L
    Cell Death Dis; 2017 Jun; 8(6):e2849. PubMed ID: 28569789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models.
    DeKoter RP; Kamath MB; Houston IB
    Blood Cells Mol Dis; 2007; 39(3):316-20. PubMed ID: 17629523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia.
    Yang XW; Wang P; Liu JQ; Zhang H; Xi WD; Jia XH; Wang KK
    Oncogene; 2014 May; 33(21):2700-8. PubMed ID: 23770850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.